Ashland (ASH) Expected to Announce Earnings on Wednesday

Ashland (NYSE:ASH - Get Free Report) is projected to announce its Q2 2025 earnings results after the market closes on Wednesday, April 30th. Analysts expect Ashland to post earnings of $1.14 per share and revenue of $514.79 million for the quarter. Ashland has set its FY 2025 guidance at EPS.

Ashland (NYSE:ASH - Get Free Report) last released its quarterly earnings data on Tuesday, January 28th. The basic materials company reported $0.28 earnings per share for the quarter, missing analysts' consensus estimates of $0.79 by ($0.51). Ashland had a negative net margin of 1.12% and a positive return on equity of 7.41%. During the same quarter in the previous year, the firm posted $0.45 earnings per share. On average, analysts expect Ashland to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Ashland Price Performance

Shares of Ashland stock traded down $0.24 on Friday, hitting $53.14. The company's stock had a trading volume of 369,540 shares, compared to its average volume of 512,662. The company has a market capitalization of $2.51 billion, a price-to-earnings ratio of -80.51, a price-to-earnings-growth ratio of 1.14 and a beta of 0.70. The firm has a fifty day moving average price of $55.88 and a 200-day moving average price of $68.54. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.27 and a current ratio of 2.52. Ashland has a 1 year low of $45.21 and a 1 year high of $102.50.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. JPMorgan Chase & Co. upgraded shares of Ashland from a "neutral" rating to an "overweight" rating and lifted their target price for the company from $68.00 to $71.00 in a research report on Wednesday, March 26th. Seaport Res Ptn cut Ashland from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. UBS Group lowered their price objective on Ashland from $95.00 to $93.00 and set a "buy" rating on the stock in a research note on Wednesday, January 29th. StockNews.com cut shares of Ashland from a "buy" rating to a "hold" rating in a research report on Thursday, February 6th. Finally, Mizuho set a $60.00 target price on shares of Ashland in a research note on Tuesday, April 15th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $73.20.

Insider Activity

In other news, CEO Guillermo Novo bought 31,294 shares of the stock in a transaction that occurred on Friday, January 31st. The stock was bought at an average cost of $64.24 per share, for a total transaction of $2,010,326.56. Following the acquisition, the chief executive officer now directly owns 31,294 shares of the company's stock, valued at $2,010,326.56. The trade was a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 1.02% of the company's stock.

Ashland Company Profile

Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.